<DOC>
	<DOC>NCT01520779</DOC>
	<brief_summary>analysis of the risk factors of intra-hepatic distant recurrence (IDR) of hepatocellular carcinoma within 1 year after radiofrequency ablation.</brief_summary>
	<brief_title>Recurrence of Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>1. Proved diagnosis of HCC according to AASLD practice guidelines (Bruix and Sherman, 2005). 2. Patients underwent RFA for HCC with BCLC (The BarcelonaClinic LiverCancer staging system) stage A (Bruix and Sherman, 2005) with no eligibility or ability to do transplantation or resection. 3. Patients should be followedup for more than 12 months to exclude early recurrence i.e. recurrence within 1 year. 4. Patients with INR &lt; 1.5 or prothrombin concentration &gt; 50%. 5. Platelet count &gt; 50000 cell/mm3. 1. Presence of extrahepatic metastasis or gross vascular invasion. 2. Child class C patients. 3. Follow up period of less than 12 months.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Hepatocellular cacinoma</keyword>
	<keyword>Radiofrequancy ablation</keyword>
	<keyword>Intrahepatic recurrence</keyword>
</DOC>